RNAZ TRANSCODE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2024 - Stockholder Approvals Transcode Therapeutics held a Special Meeting where stockholders approved the issuance of 10 million shares and a reverse stock split between 1-for-10 and 1-for-40, with sufficient votes for all proposals.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC